RMSF Training Module: Clinical Diagnosis and Treatment for Healthcare Providers (Continuing Education)

Centers for Disease Control and Prevention Quality Training logo


This enduring activity is designed to increase knowledge and change competency of Rocky Mountain spotted fever practices and strategies.

Rocky Mountain Spotted Fever: Clinical Diagnosis %26amp; Treatment An eLearning Course for Providers. Begin Course


At the conclusion of the session, the participant will be able to:

  1. Describe Rocky Mountain spotted fever epidemiology, vectors, and risk factors.
  2. Identify clinical characteristics of Rocky Mountain spotted fever.
  3. Explain importance of early clinical diagnosis and recommended Rocky Mountain spotted fever treatment.
  4. Describe available laboratory tests for Rocky Mountain spotted fever diagnosis.
  5. Explain how to prevent and respond to tick bites.
  6. Describe the importance of collaboration between clinicians and public health personnel in responding to outbreaks of Rocky Mountain Spotted Fever.


Johanna Salzer, DVM, PHD, Veterinary Medical Officer, Epidemiology Team Lead, Centers for Disease Control and Prevention

David McCormick, MD, MPH, Medical Epidemiologist, Centers for Disease Control and Prevention

        May 2, 2025

URL: RMSF Training Module: Clinical Diagnosis and Treatment for Healthcare Providers (Continuing Education) | Rocky Mountain Spotted Fever (RMSF) | CDC

HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser


TARGET AUDIENCE: Healthcare providers and public health practitioners

PREREQUISITES: Knowledge of basic biological sciences and basic epidemiologic concepts, such as descriptive epidemiology.

FORMAT: This activity is Web on Demand.

CONTACT INFORMATION: Office of Johanna Salzer, 404-639-5176


Jointly Accredited Provider Interprofessional Continuing Education logo

In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:  The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

AAPA CME: Credit Designation Statement – Enduring Materials
The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 5/2/2025. PAs should only claim credit commensurate with the extent of their participation.

CNE:  The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this Knowledge-based event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-23-036-H01-P.

After credit is claimed, an unofficial statement of credit is immediately available on Training and Continuing Education Online (TCEO).  Official credit will be uploaded within 60 days on the NABP/CPE Monitor

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.0. Continuing Competency credits available are 1.0. CDC provider number 98614.

AAVSB/RACE:  This program was reviewed and approved by AAVSB RACE program for 1.2 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments or concerns regarding this program’s validity or relevancy to the veterinary profession.

For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credits for this program.


In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WB4699-Rocky Mountain Spotted Fever: Clinical Diagnosis and Treatment please visit TCEO and follow these 9 Simple Steps before 5/2/2025.


No fees are charged for CDC’s CE activities.